Search 33,000+ CME courses
Back

StatPearls, LLC

  • Aldosterone
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Hyperkalemia
  • Hypertension

Angiotensin II Receptor Blockers (ARB)

Angiotensin II receptor blockers are a class of medications that selectively inhibit the binding of angiotensin II to the angiotensin type 1 receptor. This inhibition produces vasodilation, decreases aldosterone secretion, and lowers blood pressure. Angiotensin II receptor blockers are commonly prescribed for hypertension, congestive heart failure, and chronic kidney disease, including diabetic nephropathy. Their therapeutic role overlaps with that of angiotensin-converting enzyme inhibitors, but angiotensin II receptor blockers offer a valuable alternative for patients who experience adverse effects, such as cough or angioedema, with angiotensin-converting enzyme inhibitors. Although generally well-tolerated, angiotensin II receptor blockers may lead to hyperkalemia, hypotension, dizziness, or renal impairment. These medications are contraindicated during pregnancy and require caution in patients with bilateral renal artery stenosis. When combined with potassium-sparing diuretics or supplements, the risk of hyperkalemia increases. Their favorable safety and efficacy profiles make angiotensin II receptor blockers an important component of cardiovascular and renal disease management. Through this educational activity, the participant gains a deeper understanding of the pharmacologic properties, therapeutic applications, and safety considerations of Angiotensin II receptor blockers. Mastery of these principles enhances clinical judgment in selecting appropriate treatment strategies for individuals with hypertension and related conditions. The participant also develops greater confidence in recognizing and managing potential drug interactions and adverse reactions. Collaboration within an interprofessional healthcare team comprising physicians, pharmacists, and nurses improves patient monitoring, medication adherence, and outcomes. By integrating multidisciplinary perspectives, the team ensures comprehensive care that aligns therapeutic goals with patient safety…

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 9 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

Related courses

See all

Other providers’ courses on the same topic

More from StatPearls, LLC

See all

This provider’s courses closest to this one